<DOC>
	<DOCNO>NCT00842387</DOCNO>
	<brief_summary>The aim project compare GERD clinical outcome patient structure pathway use GerdQ questionnaire implement compare clinical outcome treat without implementation . This European project 5 participate country ( Austria , Italy , Norway , Spain Sweden ) . Due different characteristic regard actual management disease 5 country , country flexibility introduce design difference change study protocol .</brief_summary>
	<brief_title>Evaluation Study Management Strategy Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description>In Norway , develop clinical trial new structure pathway diagnosis treatment GERD compare ordinary clinical pathway consist endoscopic/pH-metry approach patient refer primary care GI specialist . In Italy , PCP-level , cluster randomize , control trial comparing structure clinical pathway versus usual care patient GERD . The implementation consist train session clinical pathway select PCPs ( Implementation Group ) . In Sweden , cluster-randomised interventional study perform within daily clinical practice purpose assess effect implementation structure clinical pathway patient identify GERD . The participate PCCs randomise ( 1:1 ) implement structure clinical pathway handle patient accord local clinical routine . In Austria Spain , cluster-randomized study develop within daily clinical practice purpose assess effect implementation structure clinical pathway GERD patient . The evaluation study take place subsequent prior implementation clinical pathway . The implementation consist detailed explanation training-materials clinical pathway select randomized pool PCCs . The implementation evaluate outside study procedure ; physician 's decision whether apply .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<criteria>Patients present symptom suggestive GERD ( heartburn regurgitation prevail symptom ) severity Patient able understand complete questionnaire Alarm symptom ( Dysphagia/odynophagia , anorexia , anaemia , unintentional weight loss , abdominal mass , upper GI bleeding ) If patient participate clinical trial , he/she take part study Any condition , investigator 's opinion , make patient 's participation study difficult</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>reflux , heartburn</keyword>
	<keyword>regurgitation</keyword>
	<keyword>acid control</keyword>
	<keyword>PPI</keyword>
	<keyword>antiacid</keyword>
	<keyword>primary care</keyword>
	<keyword>esophagitis</keyword>
</DOC>